The risk signature of our study included 8 lncRNAs (CRNDE, LINC00844, FAM66C, TUBA3FP, SNHG8, HAR1A, LINC00641, and MYCNOS), and previous evidence has suggested that these lncRNAs are closely linked to the occurrence and development of cancer. This evidence concerns the gene CRNDE and cancer.